The vitamin D receptor is necessary for 1α,25-dihydroxyvitamin D3 to suppress experimental autoimmune encephalomyelitis in mice ☆

[1]  A. Mantovani,et al.  Impairment of cytokine production in mice fed a vitamin D3-deficient diet. , 2013, Immunology.

[2]  C. Mathieu,et al.  In Vitro and In Vivo Analysis of the Immune System of Vitamin D Receptor Knockout Mice , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  Terence Dwyer,et al.  Regional Variation in Multiple Sclerosis Prevalence in Australia and Its Association with Ambient Ultraviolet Radiation , 2001, Neuroepidemiology.

[4]  H. DeLuca,et al.  Vitamin D receptor null mutant mice fed high levels of calcium are fertile. , 2001, The Journal of nutrition.

[5]  A. Norman,et al.  Ligands for the vitamin D endocrine system: different shapes function as agonists and antagonists for genomic and rapid response receptors or as a ligand for the plasma vitamin D binding protein , 2001, The Journal of Steroid Biochemistry and Molecular Biology.

[6]  Mustafa Dosemeci,et al.  Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates , 2000, Occupational and environmental medicine.

[7]  H. DeLuca,et al.  In vivo upregulation of interleukin-4 is one mechanism underlying the immunoregulatory effects of 1,25-dihydroxyvitamin D(3). , 2000, Archives of biochemistry and biophysics.

[8]  R. Kumar,et al.  Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. , 2000, Biochemical and biophysical research communications.

[9]  R. Baron,et al.  Rescue of the Skeletal Phenotype of Vitamin D Receptor-Ablated Mice in the Setting of Normal Mineral Ion Homeostasis: Formal Histomorphometric and Biomechanical Analyses1. , 1999, Endocrinology.

[10]  H. DeLuca,et al.  Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice. , 1999, The Journal of nutrition.

[11]  P. Gallien,et al.  Sensory-motor and genito-sphincter dysfunctions in multiple sclerosis. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  S. Patten,et al.  Symptomatic therapies of multiple sclerosis. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[13]  D. Dean,et al.  1,25-(OH)2D3 modulates growth plate chondrocytes via membrane receptor-mediated protein kinase C by a mechanism that involves changes in phospholipid metabolism and the action of arachidonic acid and PGE2 , 1999, Steroids.

[14]  M. A. Qureshi,et al.  Vitamin D deficiency alters the immune responses of broiler chicks. , 1998, Poultry science.

[15]  R. Baron,et al.  Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Tatsuya Yoshizawa,et al.  Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning , 1997, Nature Genetics.

[17]  H. DeLuca,et al.  1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  H. DeLuca,et al.  Effect of 1,25-dihydroxyvitamin D3 on mouse thymus: role of extracellular calcium. , 1996, Biochimica et biophysica acta.

[19]  S. Sasaki,et al.  Nutrition, latitude, and multiple sclerosis mortality: an ecologic study. , 1995, American journal of epidemiology.

[20]  A. Keskinoğlu,et al.  Lymphocyte subpopulations in children with vitamin D deficient rickets , 1995, Acta paediatrica Japonica : Overseas edition.

[21]  H. DeLuca,et al.  Vitamin D deficiency suppresses cell-mediated immunity in vivo. , 1993, Archives of biochemistry and biophysics.

[22]  J. Lemire,et al.  1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. , 1991, The Journal of clinical investigation.

[23]  J. Mcleod,et al.  Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental? , 1990, Journal of neurology, neurosurgery, and psychiatry.

[24]  M. Alter,et al.  Distribution of multiple sclerosis. , 1973, Lancet.

[25]  R. Peto,et al.  Smoking and cancer. , 1973, Lancet.

[26]  K. Westlund.  DISTRIBUTION AND MORTALITY TIME TREND OF MULTIPLE SCLEROSIS AND SOME OTHER DISEASES IN NORWAY , 1970, Acta neurologica Scandinavica.

[27]  J. Kurtzke.  ON THE FINE STRUCTURE OF THE DISTRIBUTION OF MULTIPLE SCLEROSIS , 1967, Acta neurologica Scandinavica.

[28]  S. Parodi,et al.  Mortality trend for multiple sclerosis in Italy (1974–1993) , 2004, European Journal of Epidemiology.

[29]  P. Goldberg.  Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence. (A viewpoint). Part 1. Sunlight, dietary factors and epidemiology. , 1974 .

[30]  R. Martenson,et al.  Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. , 1972, Preparative biochemistry.